GlassScriptPhysician profile
Thomas J Deluca
NPI 1154326387
$1,192.26
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $764 · 2020: $83.09 · 2021: $277 · 2023: $18.76 · 2024: $49.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $68.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $68.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $187.39 | 2019-2021 | |
| Pfizer INC. | $165.51 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $140.42 | 2019-2021 | |
| Glaxosmithkline, LLC. | $127.60 | 2019-2023 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $113.45 | 2019-2024 | Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.66 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $99.93 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $94.45 | 2019-2021 | |
| Astellas Pharma US INC | $38.27 | 2019 | |
| Amarin Pharma, INC. | $28.48 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $22.81 | 2019-2020 | |
| Sanofi Pasteur INC. | $17.54 | 2020 | |
| Lilly USA, LLC | $16.88 | 2019 | |
| Ge Healthcare | $14.06 | 2020 | |
| Shire North American Group INC | $13.94 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $10.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Deluca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.